Woodline Partners LP grew its position in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 26.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,541,019 shares of the company's stock after purchasing an additional 320,284 shares during the period. Woodline Partners LP owned about 1.29% of SunOpta worth $11,866,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Quarry LP bought a new position in SunOpta during the fourth quarter valued at about $36,000. D.A. Davidson & CO. bought a new position in SunOpta during the fourth quarter valued at about $81,000. Bayesian Capital Management LP grew its position in SunOpta by 15.2% during the fourth quarter. Bayesian Capital Management LP now owns 11,536 shares of the company's stock valued at $89,000 after buying an additional 1,523 shares during the period. Mutual Advisors LLC bought a new position in SunOpta during the fourth quarter valued at about $92,000. Finally, Quadrant Capital Group LLC grew its position in SunOpta by 15.2% during the fourth quarter. Quadrant Capital Group LLC now owns 14,542 shares of the company's stock valued at $112,000 after buying an additional 1,923 shares during the period. Hedge funds and other institutional investors own 85.39% of the company's stock.
SunOpta Price Performance
STKL opened at $6.01 on Thursday. The firm has a market cap of $706.43 million, a P/E ratio of -33.39 and a beta of 1.50. The firm has a 50-day moving average of $4.80 and a 200 day moving average of $6.44. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.53 and a current ratio of 1.20. SunOpta Inc. has a fifty-two week low of $3.65 and a fifty-two week high of $8.11.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last issued its earnings results on Wednesday, May 7th. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The firm had revenue of $201.63 million during the quarter, compared to analyst estimates of $195.09 million. SunOpta had a negative net margin of 2.74% and a positive return on equity of 7.92%. On average, research analysts expect that SunOpta Inc. will post 0.13 EPS for the current year.
Wall Street Analyst Weigh In
Separately, StockNews.com upgraded shares of SunOpta from a "sell" rating to a "hold" rating in a research report on Tuesday, March 11th.
Check Out Our Latest Stock Report on SunOpta
Insiders Place Their Bets
In other SunOpta news, SVP Bryan P. Clark sold 8,500 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $5.32, for a total transaction of $45,220.00. Following the completion of the transaction, the senior vice president now owns 28,150 shares in the company, valued at $149,758. This trade represents a 23.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.90% of the company's stock.
SunOpta Company Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.